United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Pharma Industry News Merck acquisition of OncoImmune: A strategic move to strengthen COVID-19 treatment pipeline In a significant acquisition aimed at enhancing its COVID-19 therapeutic offerings, pharmaceutical giant Merck has entered into an… bypharmanewsdailyNovember 24, 2020
